Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Proline metabolism and cancer
  2. Phang, J. M.; Liu, W.
  3. Frontiers in Bioscience-Landmark. 2012, Jan; 17: 1835-1845.
  1. 2.   Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy
  2. Chatterjee, R.; Bhattacharya, P.; Gavrilova, O.; Glass, K.; Moitra, J.; Myakishev, M.; Pack, S.; Jou, W.; Feigenbaum, L.; Eckhaus, M.; Vinson, C.
  3. Journal of Molecular Endocrinology. 2011, Jun; 46(3): 175-192.
  1. 3.   Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease
  2. Cabarcas, S. M.; Hurt, E. M.; Farrar, W. L.
  3. Current Molecular Medicine. 2010, Nov; 10(8): 741-755.
  1. 4.   The metabolism of proline as microenvironmental stress substrate
  2. Phang, J. M.; Pandhare, J.; Liu, Y. M.
  3. Journal of Nutrition. 2008 138(10): 2008S-2015S.
  1. 5.   15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain
  2. Kim, H. J.; Kim, J. Y.; Meng, Z. J.; Wang, L. H.; Liu, F.; Conrads, T. P.; Burke, T. R.; Veenstra, T. D.; Farrar, W. L.
  3. Cancer Research. 2007, Mar; 67(6): 2595-2602.
  1. 6.   Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; An, P.; Kim, H. J.; Huang, J. Q.; Clarke, R.; Osborne, C. K.; Inman, J. K.; Appella, E.; Farrar, W. L.
  3. Cancer Cell. 2006, Dec; 10(6): 487-499.
  1. 7.   Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease
  2. Adachi, M.; Kurotani, R.; Morimura, K.; Shah, Y.; Sanford, M.; Madison, B. B.; Gumucio, D. L.; Marin, H. E.; Peters, J. M.; Young, H. A.; Gonzalez, F. J.
  3. Gut. 2006, Aug; 55(8): 1104-1113.
  1. 8.   Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy
  2. Boguslavsky, R. L.; Stewart, C. L.; Worman, H. J.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 653-663.
  1. 9.   Proline oxidase, a proapoptotic gene, is induced by troglitazone - Evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms
  2. Pandhare, J.; Cooper, S. K.; Phang, J. M.
  3. Journal of Biological Chemistry. 2006, JAN 27; 281(4): 2044-2052.
  1. 10.   Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells
  2. Zhang, X.; Rodriguez-Galan, M. C.; Subleski, J. J.; Ortaldo, J. R.; Hodge, D. L.; Wang, J. M.; Shimozato, O.; Reynolds, D. A.; Young, H. A.
  3. Blood. 2004, NOV 15; 104(10): 3276-3284.
  1. 11.   PPAR gamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
  2. Nicol, C. J.; Yoon, M.; Ward, J. M.; Yamashida, M.; Fukamachi, K.; Peters, J. M.; Gonzalez, F. J.
  3. Drug Metabolism Reviews. 2004, AUG; 36(Suppl. 1): 126, Abstract 253-126, Abstract 253.
  1. 12.   PPAR-gamma represses interferon-gamma gene expression by sequestration of CBP/p300
  2. Zhang, X.; Young, H. A.
  3. Faseb Journal. 2004 18(5, Suppl. S): A1138-A1138.
  1. 13.   Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis
  2. Harman, F. S.; Nicol, C. J.; Marin, H. E.; Ward, J. M.; Gonzalez, F. J.; Peters, J. M.
  3. Nature Medicine. 2004 10(5): 481-483.
  1. 14.   Transcriptional inactivation of STAT3 by PPAR gamma suppresses IL-6-responsive multiple myeloma cells
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Huang, J. Q.; Hou, J.; Li, J.; Xiong, H.; Mihalic, K.; Zhu, H. M.; Xiao, W. H.; Farrar, W. L.
  3. Immunity. 2004 20(2): 205-218.
  1. 15.   Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis
  2. Kim, D. J.; Akiyama, T. E.; Harman, F. S.; Burns, A. M.; Shan, W. W.; Ward, J. M.; Kennett, M. J.; Gonzalez, F. J.; Peters, J. M.
  3. Journal of Biological Chemistry. 2004 279(22): 23719-23727.
  1. 16.   Interleukin (IL-4) indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor gamma activated by macrophage-derived 12/15- lipoxygenase ligands
  2. Yang, X. Y.; Wang, L. H.; Mihalic, K.; Xiao, W. H.; Chen, T. S.; Li, P.; Wahl, L. M.; Farrar, W. L.
  3. Journal of Biological Chemistry. 2002 277(6): 3973-3978.
  1. 17.   Differential regulation of chemokine gene expression by 15- deoxy-Delta(12,14) prostaglandin J(2)
  2. Zhang, X.; Wang, J. M.; Gong, W. H.; Mukaida, N.; Young, H. A.
  3. Journal of Immunology. 2001 166(12): 7104-7111.
  1. 18.   Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)
  2. Peters, J. M.; Lee, S. S. T.; Li, W.; Ward, J. M.; Gavrilova, O.; Everett, C.; Reitman, M. L.; Hudson, L. D.; Gonzalez, F. J.
  3. Molecular and Cellular Biology. 2000 20(14): 5119-5128.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel